A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH
Clinical trial NCT04378010 · TERMINATED
Trial details
- NCT number
- NCT04378010
- Sponsor
- Enanta Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2021-10-04
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.